NO792823L - Fremgangsmaate ved fremstilling av nye arginiamidderivater - Google Patents

Fremgangsmaate ved fremstilling av nye arginiamidderivater

Info

Publication number
NO792823L
NO792823L NO792823A NO792823A NO792823L NO 792823 L NO792823 L NO 792823L NO 792823 A NO792823 A NO 792823A NO 792823 A NO792823 A NO 792823A NO 792823 L NO792823 L NO 792823L
Authority
NO
Norway
Prior art keywords
arginiamide
derivatives
procedure
preparation
new
Prior art date
Application number
NO792823A
Other languages
English (en)
Other versions
NO151588B (no
NO151588C (no
Inventor
Shosuke Okamoto
Ryoji Kikumoto
Yoshikuni Tamao
Kazuo Ohkubo
Shinji Tonomura
Akiko Hijikata
Tohru Tezuka
Original Assignee
Mitsubishi Chem Ind
Shosuke Okamoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/938,711 external-priority patent/US4201863A/en
Priority claimed from US06/041,419 external-priority patent/US4258192A/en
Application filed by Mitsubishi Chem Ind, Shosuke Okamoto filed Critical Mitsubishi Chem Ind
Publication of NO792823L publication Critical patent/NO792823L/no
Publication of NO151588B publication Critical patent/NO151588B/no
Publication of NO151588C publication Critical patent/NO151588C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
NO792823A 1978-08-31 1979-08-30 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater NO151588C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/938,711 US4201863A (en) 1974-11-08 1978-08-31 N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US06/041,419 US4258192A (en) 1977-12-16 1979-05-22 N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof

Publications (3)

Publication Number Publication Date
NO792823L true NO792823L (no) 1980-03-03
NO151588B NO151588B (no) 1985-01-21
NO151588C NO151588C (no) 1985-05-08

Family

ID=26718116

Family Applications (1)

Application Number Title Priority Date Filing Date
NO792823A NO151588C (no) 1978-08-31 1979-08-30 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater

Country Status (17)

Country Link
EP (1) EP0008746B1 (no)
AU (1) AU520342B2 (no)
CA (1) CA1135698A (no)
CS (1) CS228119B2 (no)
DD (1) DD146600A5 (no)
DE (1) DE2963539D1 (no)
DK (1) DK152495C (no)
ES (1) ES483767A1 (no)
FI (1) FI66183C (no)
GR (1) GR64905B (no)
HU (1) HU179734B (no)
IE (1) IE48623B1 (no)
NO (1) NO151588C (no)
NZ (1) NZ191434A (no)
PH (1) PH15662A (no)
PL (1) PL121663B1 (no)
PT (1) PT70130A (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5993054A (ja) * 1982-11-18 1984-05-29 Asahi Chem Ind Co Ltd イソキノリンスルホン酸アミド誘導体
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
US5585498A (en) * 1992-03-30 1996-12-17 Synthelabo Imidazole derivatives useful as synthetic intermediates
FR2689130B1 (fr) 1992-03-30 1994-05-27 Synthelabo Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.
GB9209032D0 (en) * 1992-04-25 1992-06-10 Ciba Geigy Ag New peptide derivatives
JPH06219949A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
JPH06219948A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
FR2702220B1 (fr) * 1993-03-03 1995-05-12 Synthelabo Dédoublement enzymatique de dérivés de 4-alkyl-2-pipéridine-carboxylate et utilisation des composés obtenus, comme intermédiaires de synthèse.
EP0621036B1 (en) * 1993-04-22 1999-03-17 Senju Pharmaceutical Co., Ltd. Aqueous compositions comprising argatroban and cyclodextrin or caffeine
FR2710067B1 (fr) * 1993-09-14 1995-10-20 Synthelabo Procédé de préparation de 2-amino-5-(1H-imidazol-4-yl)-1-oxopentylpipéridine.
FR2710066B1 (fr) * 1993-09-14 1995-10-20 Synthelabo Dérivés de 1-[2-amino-5-[1-(triphénylméthyl-1H-imidazol-4-yl]-1-oxopentyl]piperidine, leur préparation et leur utilisation comme intermédiaires de synthèse.
FR2710061B1 (fr) * 1993-09-14 1995-12-29 Synthelabo Acides et chlorures d'acides 1,2,3, 4-tétrahydroquinoléine-8-sulfoniques, et leur utilisation comme intermédiaires de synthèse.
FR2715566B1 (fr) * 1994-02-03 1996-03-08 Synthelabo Solutions aqueuses concentrées d'argatroban.
FR2718439B3 (fr) * 1994-04-12 1996-02-09 Synthelabo Dérivés de l'acide pipécolique, leur préparation et leur utilisation comme intermédiaires de synthèse.
DE4424828A1 (de) * 1994-07-14 1996-01-18 Thomae Gmbh Dr K Neue substituierte Arylsulfonamide, ihre Herstellung und ihre Verwendung als Arzneimittel
GB9505538D0 (en) * 1995-03-18 1995-05-03 Ciba Geigy Ag New compounds
GB9508622D0 (en) * 1995-04-28 1995-06-14 Pfizer Ltd Therapeutic agants
FR2735469B1 (fr) * 1995-06-13 1997-07-11 Synthelabo N2-(arylsulfonyl)-l-arginylpiperidin-2-carboxylates, leur preparation et leur application en therapeutique
FR2747676B1 (fr) * 1996-04-22 1998-06-05 Synthelabo Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
ATE207482T1 (de) * 1996-08-07 2001-11-15 Mitsubishi Chem Corp Verfahren zur herstellung von n2-arylsulfonyl-l- argininamiden
FR2804682B1 (fr) * 2000-02-09 2002-05-03 Rhodia Chimie Sa Procede de preparation diastereoselective de piperidines fonctionnalisees en positions 2 et 4 utilisables comme intermediaires de synthese
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
CN100427480C (zh) * 2006-11-10 2008-10-22 天津市炜杰科技有限公司 阿加曲班水合物的制备方法
US7915290B2 (en) 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
CN101914133B (zh) * 2008-03-07 2013-01-30 天津市炜杰科技有限公司 一种21(s)阿加曲班的定向合成方法
ITPD20080106A1 (it) 2008-04-07 2009-10-08 Lundbeck Pharmaceuticals Italy Spa Metodo di preparazione di argatroban monoidrato
EP2305646A1 (en) 2009-10-02 2011-04-06 Enantia, S.L. A process for the preparation of trans-(2R)-4-substituted-pipecolic acids and esters thereof, and intermediate compounds used therein
ITMI20110545A1 (it) 2011-04-04 2012-10-05 Lundbeck Pharmaceuticals Italy S P A Metodo per la preparazione di intermedi di processo per la sintesi di argatroban monoidrato
CN103570803B (zh) * 2012-08-30 2015-06-03 上海科胜药物研发有限公司 一种阿加曲班中间体的制备方法
CN104672132B (zh) * 2013-11-28 2017-06-16 四川科瑞德制药股份有限公司 阿加曲班中间体的合成方法
CN104098647B (zh) * 2014-06-24 2017-12-08 安徽省逸欣铭医药科技有限公司 阿加曲班类似物及其制备方法和医药用途
CN106928199B (zh) * 2017-05-08 2020-06-09 安徽医学高等专科学校 一种嘧啶化合物的晶型c的制备方法和用途
CN109912570A (zh) * 2019-04-04 2019-06-21 天津药物研究院药业有限责任公司 一种阿加曲班中间体酰胺化物的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1131621A (en) * 1977-01-19 1982-09-14 Shosuke Okamoto N.sup.2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
FI66183B (fi) 1984-05-31
DK152495C (da) 1988-07-25
PT70130A (en) 1979-09-01
GR64905B (en) 1980-06-07
AU5048679A (en) 1980-03-06
HU179734B (en) 1982-12-28
DK364579A (da) 1980-03-01
EP0008746B1 (en) 1982-08-11
IE48623B1 (en) 1985-03-20
DK152495B (da) 1988-03-07
ES483767A1 (es) 1980-04-16
NO151588B (no) 1985-01-21
AU520342B2 (en) 1982-01-28
EP0008746A1 (en) 1980-03-19
FI792637A (fi) 1980-03-01
PL218008A1 (no) 1980-05-05
DE2963539D1 (en) 1982-10-07
NZ191434A (en) 1984-07-06
DD146600A5 (de) 1981-02-18
PH15662A (en) 1983-03-11
FI66183C (fi) 1984-09-10
PL121663B1 (en) 1982-05-31
CA1135698A (en) 1982-11-16
IE791565L (en) 1980-02-29
NO151588C (no) 1985-05-08
CS228119B2 (en) 1984-05-14

Similar Documents

Publication Publication Date Title
NO792760L (no) Fremgangsmaate ved fremstilling av nye nafthydrinderivater
NO792823L (no) Fremgangsmaate ved fremstilling av nye arginiamidderivater
NO803868L (no) Fremgangsmaate ved fremstilling av nye kinazolinderivater
NO800650L (no) Fremgangsmaate ved fremstilling av nye indolderivater
NO794327L (no) Fremgangsmaate ved fremstilling av nye peptidylargininaldehyd-derivater.
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO801015L (no) Fremgangsmaate ved fremstilling av nye piperidinderivater
NO801155L (no) Fremgangsmaate ved fremstilling av acyl-carnitinamider
NO791831L (no) Fremgangsmaate for fremstilling av aminotiazoler
NO801855L (no) Fremgangsmaate ved fremstilling av nye enkafalinderivater
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO792474L (no) Fremgangsmaate ved fremstilling av indanyl-derivater
NO150155C (no) Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser
NO781168L (no) Fremgangsmaate ved fremstilling av diasepinderivater
NO150156C (no) Fremgangsmaate ved fremstilling av 5(6)-thio-benzimidazolderivater
NO150799C (no) Fremgangsmaate for fremstilling av lysergol-derivater
FI791562A (fi) Foerfarande foer framstaellning av 4-amino-2-piperidinokinazolinderivat
NO803247L (no) R fremgangsmaate ved fremstilling av nye pyridothienotriazine
NO802402L (no) R fremgangsmaate ved fremstilling av nye halovincamonderivate
NO803044L (no) Fremgangsmaate ved fremstilling av nye derivater av 1,2,4-oxadiazolin-5-on
NO801982L (no) Fremgangsmaate ved fremstilling av svovelholdige isokinolinderivater
NO152254C (no) Fremgangsmaate til fremstilling av karbazolderivater
NO147310C (no) Fremgangsmaate for fremstilling av substituerte antitumorantracykliner
NO791220L (no) Fremgangsmaate ved fremstilling av 4-aza-17-substituert-5alfa-androstan-3-oner
NO794090L (no) Fremgangsmaate for fremstilling av klordioksyd